Ustekinumab in the Treatment of Crohn’s Disease—A Narrative Review on Clinical Efficacy and Safety Profile
Crohn’s disease (CD) is a chronic inflammatory disorder of the gastrointestinal tract that leads to significant deterioration in patients’ quality of life. Biologic therapy, including the use of ustekinumab (UST), is a modern approach to treating the moderate to severe form of CD, especially in pati...
Saved in:
Main Authors: | Dawid Piecuch, Edyta Hańczyk, Szymon Kopciał, Natalia Pawelec, Weronika Mazur, Karolina Kornatowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-05-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/13/3/73 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Possibilities for the Treatment of Crohn’s Disease
by: Z. A. Mamieva, et al.
Published: (2019-12-01) -
Case Report: Successful treatment of refractory synovitis, acne, pustulosis, hyperostosis, and osteitis syndrome and palmoplantar pustulosis with ustekinumab
by: Luxia Chen, et al.
Published: (2025-07-01) -
Machine learning gene expression predicting model for ustekinumab response in patients with Crohn's disease
by: Manrong He, et al.
Published: (2021-12-01) -
Features of interleukin-17 and interleukin-23 expression in patients with inflammatory bowel diseases
by: Yu.M. Stepanov, et al.
Published: (2025-03-01) -
Short-Term Effectiveness of Ustekinumab in Crohn’s Disease: Results from a Real-World Retrospective Multicenter Study in China
by: Zhu X, et al.
Published: (2025-05-01)